Last deal

$1.9M
Local Amount - GBP 1.2M

Amount

Grant

Stage

01.09.2013

Date

3

all rounds

$8M

Total amount

General

About Company
Canbex Therapeutics is a drug development company focused on the treatment of spasticity in multiple sclerosis.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Canbex

founded date

01.01.2005

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

By offering cannabinoid agonists, Canbex Therapeutics aims to alleviate the debilitating symptoms of spasticity, including involuntary spasms and stiffness in limbs and torso. With a mission to enhance the lives of individuals suffering from this incurable condition, the company is dedicated to setting a new standard in spasticity treatment.
Contacts